Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05407844
Other study ID # IRB00283002
Secondary ID 1R01CA252101-01A
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date November 2, 2023
Est. completion date September 1, 2027

Study information

Verified date November 2023
Source Johns Hopkins University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study aims to find out if community health worker (CHW) support will improve palliative care outcomes in African American patients with advanced cancer, by comparing the quality of life of patients who are receiving standard care to those whose standard care is supplemented with CHW support.


Description:

This research is being done to establish the effectiveness of a Community Health Worker based palliative care intervention among African American patients with advanced solid organ malignancies and their care givers. The investigators' long-term goal is to reduce the research-to-practice gap in utilization of evidence-based palliative care in African Americans with advanced cancer. The objectives of this study are to establish the effectiveness of a CHW-based palliative care intervention and develop generalizable knowledge on how contextual factors influence implementation.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 310
Est. completion date September 1, 2027
Est. primary completion date June 1, 2027
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Patient Inclusion Criteria: - Self-identified African American patients with advanced (AJCC stage III or IV) solid organ malignancy - >18 years old - English speaking - Intact cognition and ability to provide informed consent Patient Exclusion Criteria: - Participants < 18 years of age - Participants who are already receiving palliative care services Caregiver Inclusion Criteria: - Adult (>18 years old) caregivers providing informal (unpaid) care to an eligible African American cancer patient (related or unrelated) - >18 years old - English speaking - Intact cognition and ability to provide informed consent Caregiver Exclusion Criteria: - Participants < 18 years of age

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Community Health Worker (CHW) based palliative care
Those in the intervention group will receive support from a dedicated CHW trained in motivational interviewing, components of palliative care communication, and social determinants of health.

Locations

Country Name City State
United States Johns Hopkins University School of Medicine Baltimore Maryland

Sponsors (3)

Lead Sponsor Collaborator
Johns Hopkins University National Cancer Institute (NCI), National Institute on Minority Health and Health Disparities (NIMHD)

Country where clinical trial is conducted

United States, 

References & Publications (1)

Johnston FM, Neiman JH, Parmley LE, Conca-Cheng A, Freund KM, Concannon TW, Smith TJ, Cooper LA. Stakeholder Perspectives on the Use of Community Health Workers To Improve Palliative Care Use by African Americans with Cancer. J Palliat Med. 2019 Mar;22(3):302-306. doi: 10.1089/jpm.2018.0366. Epub 2018 Nov 2. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Number of participants who completed Advance Directives Advanced care planning 6 months after enrollment
Secondary Functional Assessment of Chronic Illness Therapy-Palliative Subscale (FACIT-PAL) score Quality of Life; Score range: 0-184 [per scoring document, for total score] Higher scores signify better quality of life 6 months after enrollment
Secondary Number of participants who utilize hospice care Hospice care utilization within 14 days of death (Yes/No) 6 months after enrollment
Secondary Goals of care as assessed by Quality of communication (QOC) scale Goals of Care; Score range: 0-10 [scored 0-10 for each of 19 components] Higher scores signify: higher quality communication with physician 6 months after enrollment
Secondary Symptom Intensity as assessed by the Edmonton Symptom Assessment Score (ESAS) Symptom; Score range: 0-10 [scored 0-10 for 10 components] Higher scores signify: higher intensity of cancer symptoms (worse symptoms) 6 months after enrollment
Secondary Depression as assessed by the Center for Epidemiologic Studies Depression Scale (CES-D) Symptom; The score is the sum of the 20 questions. Possible range is 0-60. A score of 16 points or more is considered depressed. 6 months after enrollment
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases